Apparently "low" serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes

Date
2014
Author
KOROGLU, Bayram
KARAGÖZ, Ahmet
Yuksel, Murat
Aydin, Mesut
Onat, Altan
Can, Günay
Metadata
Show full item record
Abstract
Objective: We investigated the association of serum asymmetric dimethylarginine (ADMA) with metabolic syndrome (MetS), type-2 diabetes and coronary heart disease (CHD) in the general population.
URI
http://hdl.handle.net/20.500.12627/91493
https://doi.org/10.5152/akd.2013.5009
Collections